Pathogenic Factors and Immunological Treatment of Cervical Cancer

• Main Authors: Qin Qingying, He Wenyuan, Wang Guxian
• Format: Article
• Language: English
• Published: EDP Sciences 2020-01-01
• Series: E3S Web of Conferences
• Online Access: https://www.e3s-conferences.org/articles/e3sconf/pdf/2020/78/e3sconf_iseese2020_03015.pdf

This paper attempts to analyze the related factors of cervical cancer combined with immunotherapy, taking cervical cancer patients as the experimental object, through the establishment of cervical cancer model, combined with natural immune agonists, immune activated monoclonal antibody and HPV polypeptide to explore its prevention or treatment of cervical cancer immune research.The results showed that the number of people with bad habits was more, and the incidence rate of cervical cancer was relatively high. However, for those without formal work, the number of cases of bad sexual behavior is more, and HPV transmission is easier, which also provides convenience for the occurrence of cervical cancer. The mechanism of action of tumor therapeutic vaccine is different from that of cytotoxic drugs. Its particularity lies in that the induction of specific anti-tumor immune response needs a certain period of time before it can be transformed into clinical effect; and patients with recurrence or metastasis usually receive multiple rounds of treatment, which may affect the immune system and reduce the efficacy of the vaccine.